AI Article Synopsis

  • Up to 50% of essential tremor patients don't respond to medication, leading researchers to explore MRgFUS as an alternative treatment compared to other interventions like DBS and thalamotomy.
  • A systematic review analyzed clinical and economic evidence, with a focus on safety and efficacy, revealing all treatments have varying effectiveness and safety profiles.
  • The study found that MRgFUS shows comparable short-term benefits for tremor relief and quality of life to unilateral DBS, suggesting it could be a viable option for medication-refractory patients.

Article Abstract

Background: Up to 50% of essential tremor patients are refractory to medication and require alternative treatment to achieve tremor relief. This study aimed to identify and analyze evidence supporting the use of the emerging magnetic resonance-guided focused ultrasound (MRgFUS) compared to alternative stimulatory and ablative interventions for the treatment of medication-refractory essential tremor: radiofrequency thalamotomy, unilateral deep brain stimulation (DBS), and stereotactic radiosurgery.

Methods: A systematic literature review was conducted to identify clinical, health-related quality of life (HRQoL), and economic evidence for each intervention. Because of the lack of comparative evidence captured, a feasibility assessment was performed to determine possible comparisons between interventions, and newly established matching-adjusted indirect comparison and simulated treatment comparison techniques were used to conduct a comparison between unilateral DBS aggregate data and MRgFUS individual patient data.

Results: The systematic literature review identified 1,559 records, and screening yielded 46 relevant articles. The captured studies demonstrated that radiofrequency thalamotomy, DBS, stereotactic radiosurgery, and MRgFUS all exhibit clinical efficacy, with variation in onset and duration of tremor relief, and are each associated with a unique safety profile. The matching-adjusted indirect comparison and simulated treatment comparison results demonstrated no evidence of a difference in efficacy (measured by Clinical Rating Scale for Tremor Total) and HRQoL (measured by Clinical Rating Scale for Tremor Part C) outcomes between MRgFUS and unilateral DBS in the short term (≤12 months).

Conclusions: This study provides preliminary evidence that MRgFUS could elicit similar short-term tremor- and HRQoL-related benefits to DBS, the current standard of care, and allowed for the first robust statistical comparison between these interventions.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jval.2018.03.015DOI Listing

Publication Analysis

Top Keywords

essential tremor
12
indirect comparison
12
focused ultrasound
8
medication-refractory essential
8
health-related quality
8
quality life
8
tremor relief
8
radiofrequency thalamotomy
8
dbs stereotactic
8
systematic literature
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!